Mortality over a period of 10 years in patients with peripheral arterial disease

New England Journal of Medicine

Volumn 326, Issue 6, 1992, Pages 381-386

  Criqui, Michael H ^a,a   Langer, Robert D ^a   Feigelson, Heather S ^a   Klauber, Melville R ^a   Mccann, Theresa J ^a   Browner, Deirdre ^a   Fronek, Arnost ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; DOPPLER FLOWMETRY; FEMALE; HUMAN; INTERMITTENT CLAUDICATION; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; TIBIAL ARTERY; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0026501734     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199202063260605     Document Type: Article

References (30)

1. Criqui M.H., Coughlin S.S., Fronek A. Noninvasively diagnosed peripheral arterial disease as a predictor of mortality: results from a prospective study. Circulation 1985; 72:768-773
2. The Lipid Research Clinics Program Epidemiology Committee. Plasma lipid distribution in selected North American populations: the Lipid Research Clinics Program Prevalence Study. Circulation 1979; 60:427-439
3. Criqui M.H., Fronek A., Barrett-Connor E., Klauber M.R., Gabriel S., Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation 1985; 71:510-515
4. Rose G.A. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull World Health Organ 1962; 27:645-658
5. Winsor T. Influence of arterial disease on the systolic blood pressure gradients of the extremity. Am J Med Sci 1950; 220:117-126
6. Fronek A., Johansen K.H., Dilley R.B., Bernstein E.F. Noninvasive physiologic tests in the diagnosis and characterization of peripheral arterial occlusive disease. Am J Surg 1973; 126:205-214
7. Strandness D.E. Jr. Peripheral arterial disease: a physiologic approach. Boston: Little, Brown, 1969.
8. Fronek A. Noninvasive diagnostics in vascular disease. New York: McGraw-Hill, 1989: 88-94.
9. Fronek A., Coel M., Bernstein E.F. Quantitative ultrasonographic studies of lower extremity flow velocities in health and disease. Circulation 1976; 53: 957-60.
10. National Heart and Lung Institute, National Institutes of Health. Manual of laboratory operations: Lipid Research Clinics Program. Vol. 1. Lipid and lipoprotein analysis. Washington, D.C.: Government Printing Office, 1975. (DHEW publication no. (NIH) 75–628.)
11. Department of Health and Human Services. The international classification of diseases, 9th revision, clinical modification: ICD-9-CM. 3rd ed. Washington, D.C.: Government Printing Office, 1989. (DHHS publication no. (PHS) 89–1260.)
12. Criqui M.H., Browner D., Fronek A., et al. Peripheral arterial disease in large vessels is epidemiologically distinct from small vessel disease: an analysis of risk factors. Am J Epidemiol 1989; 129:1110-1119
13. Cox D.R. Regression models and life-tables. J R Stat Soc [B] 1972; 34:187-220.
14. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1985; 53:457-481
15. Peabody C.N., Kannel W.B., McNamara P.M. Intermittent claudication: surgical significance. Arch Surg 1974; 109:693-697
16. Hughson W.G., Mann J.I., Tibbs D.J., Woods H.F., Walton I. Intermittent claudication: factors determining outcome. BMJ 1978; 1:1377-1379
17. Reunanen A., Takkunen H., Aromaa A. Prevalence of intermittent claudication and its effect on mortality. Acta Med Scand 1982; 211:249-256
18. Jelnes R., Gaardsting O., Hougaard-Jensen K., Baekgaard N., Tønnesen K.H., Schroeder T. Fate in intermittent claudication: outcome and risk factors. BMJ 1986; 293:1137-1140
19. Dormandy J., Mahir M., Ascady G., et al. Fate of the patient with chronic leg ischaemia. J Cardiovasc Surg (Torino) 1989; 30:50-57
20. Smith G.D., Shipley M.J., Rose G. Intermittent claudication, heart disease risk factors, and mortality: the Whitehall Study. Circulation 1990; 82:1925-1931
21. Criqui M.H., Fronek A., Klauber M.R., Barrett-Connor E., Gabriel S. The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from a noninvasive testing in a defined population. Circulation 1985; 71:516-522
22. Criqui M.H. Peripheral arterial disease and subsequent cardiovascular mortality: a strong and consistent association. Circulation 1990; 82:2246-2247
23. Jonason T., Bergstrom R. Cessation of smoking in patients with intermittent claudication: effects on the risk of peripheral vascular complications, myocardial infarction and mortality. Acta Med Scand 1987; 221:253-260
24. Hermanson M.S., Omenn G.S., Kronmal R.A., Gersh B.J. Participants in the Coronary Artery Surgery Study. Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease: results from the CASS registry. N Engl J Med 1988; 319:1365-1369
25. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA 1984; 251:351-364
26. Canner P.L., Berge G.K., Wenger N.K., et al. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol 1986; 18:1245-1255
27. Brown G., Albers J.J., Fisher L.D., et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990; 323:1289-1298
28. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment of morbidity in hypertension: results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA 1967; 202:1028-1034
29. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment of morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 1970; 213:1143-1152
30. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 1979; 242:2562-2571